ArticleBMC medical imaging2026
End-to-end 2.5D multisequence-multichannel fusion model for preoperative survival prediction in glioma: a retrospective study.
Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gliomas are the most common primary malignant tumors of the central nervous system and show marked imaging heterogeneity, making accurate preoperative prediction of 24-month overall survival status important for individualized treatment planning and prognostic counseling. Summary receiver operating characteristic analyses were used to systematically compare combinations of convolutional backbone depth and input channel counts to identify an optimal sequence-channel configuration. Guided by these findings, we developed an end-to-end multisequence-multichannel fusion aggregation (EMFA) framework that integrates deep transfer learning image representations with radiomics features. A multi-instance learning (MIL) module was further incorporated to enable adaptive within-sequence weighting and cross-sequence feature aggregation, improving model interpretability. In the held-out test cohort, the EMFA framework achieved an area under the receiver operating characteristic curve (AUC) of 0.899 and an accuracy of 0.935 (93.5%), showing competitive performance relative to corresponding single-sequence baselines. The configuration analysis indicated that nine-channel inputs for T1-weighted and T2-weighted imaging and a three-channel input for contrast-enhanced T1-weighted imaging provided the best overall performance. These results suggest that EMFA offers an effective and scalable strategy for fusing multisequence magnetic resonance imaging (MRI) information for 24-month glioma survival-status prediction, supporting imaging-informatics-driven clinical decision support and potential future translation into neuroradiology workflows.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.